Clinical Trial Update: BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating BAL, BOT, and agenT-797 in metastatic colorectal cancer with liver metastases; recruitment has not started yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BAL
• BOT
• agenT-797 (agenT-797)

Snippet

Sponsor: Darren Sigal, MD | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING